Investigational Therapeutics for the Treatment of People With Ebola Virus Disease

NCT03719586 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

681

Enrollment

NIH

Sponsor class

Conditions

Ebola Virus

Interventions

DRUG: ZMapp
DRUG: Remdesivir
DRUG: MAb114
DRUG: REGN-EB3

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)